6P5-10419-77881
4 vaccinations
2 coded responses
16 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 553 / MN
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-17
Dose 1 — Pfizer-BioNTech
-
2021-03-10
Dose 2 — Pfizer-BioNTech
-
2021-03-17
Registered in v-safe
- 2021-03-17
- 2021-03-26
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-06-09
- 2021-09-10
-
2021-10-14
Dose 3 — Pfizer-BioNTech
- 2022-03-10
-
2022-10-14
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-20
-
2022-10-21
Survey response — day 7, dose 4MedDRA: Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-10-28
Survey response — day 14, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid 19MedDRA releases: 2024-11 · check-in free text available
- 2022-11-09
- 2022-11-11
- 2022-11-18
- 2022-11-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-17 | Pfizer-BioNTech | |
| 2 | 2021-03-10 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
| 4 | 2022-10-14 | Pfizer-BioNTech | Flu |
Free text
Release 12 — day 7, dose 4
Systemic reaction (other): Runny nose
Release 12 — day 14, dose 4
Symptoms: Covid 19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release